Chief, Dermatology, Division of Subspecialty Medicine | Department of Medicine

About Us:

The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it.

MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe.

The Division of Subspecialty Medicine in the Department of Medicine seeks an exceptional academic dermatologist and visionary leader to serve as Chief of the Dermatology Service . This is an extraordinary opportunity to lead one of the nation's premier oncologic dermatology programs and to advance innovation in patient care, research, education, and multidisciplinary collaboration across the cancer continuum.

The Dermatology Service The Dermatology Service is an internationally recognized group of faculty with expertise in the prevention, diagnosis, treatment, and research of skin cancers and skin toxicities related to cancer therapies. The Service faculty provides comprehensive care for patients with melanoma, non-melanoma skin cancers, rare cutaneous malignancies, and dermatologic complications arising from cancer treatment. Faculty members also provide specialized expertise in oncodermatology, Mohs micrographic surgery, dermatologic surgery, advanced imaging, and dermatology informatics.

The Service is distinguished by its multidisciplinary approach to care, partnering closely with colleagues across Medical Oncology, Surgical Oncology, Radiation Oncology, Pathology, Radiology, Plastic Surgery, Immunology, and other clinical specialties to deliver personalized care for patients throughout the cancer continuum. Faculty are internationally recognized leaders in reflectance confocal microscopy, digital dermoscopy, three-dimensional total body photography, artificial intelligence applications in dermatology, and other emerging technologies that advance the early detection and management of skin cancer.

The Service Chief will report to the Head of the Division of Subspecialty Medicine and will provide strategic, clinical, academic, and operational leadership for the Dermatology Service. The Chief will be responsible for advancing the Service's clinical excellence, research portfolio, educational mission, faculty development, philanthropy, and impact on the management of cutaneous malignancies and dermatologic manifestations of cancer and its treatment worldwide.

The Service Chief will oversee clinical operations, faculty recruitment and retention, mentorship, quality improvement, strategic growth, and collaborations across Memorial Sloan Kettering while fostering innovation in patient care and translational research.

The clinical, research, and educational mission of the Dermatology Service is organized around six strategic pillars:
1. Cutaneous Oncology:
Lead the continued advancement of comprehensive multidisciplinary care for patients with melanoma, basal cell carcinoma, squamous cell carcinoma, Merkel cell carcinoma, cutaneous lymphomas, and other rare skin malignancies. Promote innovations in prevention, diagnosis, treatment, and survivorship for patients with skin cancer.
2. Oncodermatology:
Advance programs dedicated to preventing, diagnosing, and managing dermatologic toxicities associated with systemic therapies, radiation therapy, stem cell transplantation, and immunotherapy. Continue developing evidence-based approaches that improve quality of life while enabling patients to remain on life-saving cancer treatments.
3 Procedural Dermatology :
Advance excellence in Mohs micrographic surgery, dermatologic surgery, laser therapies, photodynamic therapy, photobiomodulation, and reconstructive approaches that maximize oncologic control while preserving function and appearance.
4. Innovation in Dermatologic Imaging and Technology:
Expand MSK's leadership in non-invasive imaging technologies, including reflectance confocal microscopy, digital dermoscopy, total body photography, artificial intelligence, and dermatology informatics. Foster collaborations that accelerate precision diagnostics and improve early detection of skin cancer.
5. Research and Innovation :
The successful…